European Investment Bank

Orano is a leading global company based in Courbevoie, France, specializing in nuclear power and renewable energy solutions. The company offers a comprehensive range of services covering every stage of the nuclear fuel cycle, including reactor design, construction, and operational support. With a strong emphasis on safety and advanced technology, Orano is committed to supplying low-carbon power generation solutions. Additionally, it engages in renewable energy initiatives through partnerships aimed at developing high-tech solutions. As energy demand increases and the need for sustainable practices intensifies, Orano focuses on creating cleaner energy alternatives that contribute to reducing greenhouse gas emissions. The company aims to enhance transparency, coherence, and efficiency in its operations while preparing for the future energy landscape.

Infrastrutture Wireless Italiane S.p.A. (INWIT) is a leading provider of telecommunications infrastructure in Italy, specializing in the construction and operation of mobile communication towers. Established in 2015 from the spinoff of Telecom Italia's tower assets, the company manages approximately 11,000 sites across the country, hosting the transmission apparatuses of major national operators. INWIT offers a range of integrated services, including the design and construction of new sites, micro cells, and distributed antenna systems (DAS) to enhance wireless coverage in urban areas, large venues, and healthcare facilities. The company plays a crucial role in the expansion of wireless telephony services, particularly with the development of 5G technology. INWIT serves a diverse clientele, including network operators and public institutions, and has established a significant presence in the telecommunications sector through its merger with Vodafone Italia's tower assets.

Universal Diagnostics S.L. (UDX) is a Spanish in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early. The UDX diagnostic platform is designed to detect various cancer types, e.g. colorectal, liver, pancreatic, lung, and gastric cancer via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis. UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I). To develop the test and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe.

Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

Median Technologies SA specializes in the development and marketing of software products and platforms for medical image analysis, primarily focusing on oncology. Founded in 2002 and headquartered in Valbonne, France, the company operates internationally, offering solutions that enhance the diagnosis and treatment of cancer patients. Its key products include iBiopsy, an imaging platform that utilizes AI for biomarker identification, and iSee, which supports image analysis and management in clinical trials. Additionally, Median provides a range of imaging contract research services, including study startup, data management, and scientific consulting to optimize clinical trials. The company collaborates with a contract research organization and Canon to enhance its imaging technologies and services, aiming to improve patient care and streamline drug development processes.

EDP Renewables (Euronext: EDPR) is a , global renewable energy company devoted to value creation, innovation and sustainability. They operate in markets around the globe and are continuously expanding their business to new regions, making the commitment to lead in each market as well as create value for their stakeholders and shareholders. EDPR has developed wind farms since 1996 and was first listed publicly in June 2008. EDPR’s global presence is managed by two regional platforms which oversee the development, construction and operation of assets in their geographic areas. EDPR Europe, headquartered in Madrid, manages assets located in the European Union, and other Regions renewable energy assets of the EDP Group and EDPR North America, headquartered in Houston, manages assets in the United States and Canada. EDPR is committed to operational excellence through high-quality assets and attractive markets which provide highly attractive possibilities, principally due to their growth prospects and stable regulatory structure that permit profit generation. Energias de Portugal, S.A. (“EDP”), a vertically-integrated utility company, headquartered in Lisbon, Portugal, is the majority shareholder of EDPR. EDP Group is Portugal´s largest industrial group and one of Europe´s primary energy companies. Currently, it is the Iberian Peninsula´s third largest energy operator with business interests in generation, distribution and supply of electricity and gas in Portugal and Spain. Additional to its leadership position in the Iberian Peninsula, EDP Group also holds a significant position in the Brazilian electricity sector

EDP ​​is a global energy company in value creation, innovation and sustainability. They include in their cultural values and commitments regarding their customers, society, and environment. Their vision to be an integrated energy company, a leader in value creation in the markets where they can make a difference is shared by the universe of EDP employees, spread across different continents and countries, a diversity that enriches us and brings us together in the respect for the different cultures of the markets where they operate. They are among the major European operators in the energy sector; they are one of the largest energy operators of the Iberian Peninsula, the largest Portuguese industrial group and the 3rd largest producer of wind energy. Besides the electricity sector - generation, distribution, and trading - they also have a significant presence in the gas sector of the Iberian Peninsula. They integrate the Dow Jones Sustainability Indexes (World and STOXX), the world's most demanding ranking, that distinguishes the best-performing companies on issues related to transparency, sustainability, and excellence in economic management and social environment. EDP was founded in 1976 and is headquartered in Lisboa, Portugal.

ERG is a leading wind power operator in Italy and ranks among the top ten in Europe, specializing in the production of electricity from clean, renewable, and sustainable sources. With a legacy of 80 years, the company harnesses a combination of wind and solar energy, alongside hydroelectric and natural gas operations. ERG's wind power initiatives are managed by its subsidiary, ENG Renew, which focuses on the development, construction, and operation of wind assets. Additionally, ERG Power Generation oversees its hydroelectric and natural gas operations, which include various plants, dams, reservoirs, and a pumping station. This diversified approach allows ERG to supply electricity to markets across Europe while maintaining a commitment to sustainability.

Cellectis S.A. is a clinical-stage biotechnological company headquartered in Paris, France, focused on developing immuno-oncology products utilizing gene-edited T-cells that express chimeric antigen receptors to target cancer cells. The company's primary portfolio includes several allogeneic T-cell product candidates such as UCART19, designed for treating CD19-expressing hematologic malignancies, and UCART123 for acute myeloid leukemia. Additional candidates include ALLO-501 for relapsed/refractory diffuse large B-cell lymphoma, UCART22 for B-cell acute lymphoblastic leukemia, and products targeting multiple myeloma, such as UCARTCS1 and ALLO-715. In addition to its therapeutic developments, Cellectis also produces high oleic soybean oil and other agricultural products. The company has established strategic partnerships with various institutions, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to innovate in the field of gene editing and immunotherapy.

Enpal GmbH, founded in 2017 and based in Berlin, Germany, specializes in providing all-in-one renewable energy solutions, including solar panels, battery systems, wallboxes, heat pumps, and energy management systems. The company focuses on making renewable energy accessible and affordable for customers in Germany and Italy through a unique leasing model that requires no upfront payment. This model covers installation, insurance, and maintenance, attracting customers who prefer to avoid high initial investments. Enpal has successfully installed over 60,000 solar photovoltaic systems, becoming the market leader in Germany. The company employs more than 1,000 staff, including over 200 local installer teams, and has opened several satellite offices to enhance customer service. Enpal has received numerous accolades, including awards for sustainability and customer service. In recent years, it has diversified its offerings and introduced a sales option to accommodate customers interested in purchasing their solar solutions. In 2022, Enpal reported revenues exceeding 400 million euros and has been recognized as one of Germany's fastest-growing companies.

Fab'entech, founded in 2009 in Lyon, France, is a biopharmaceutical company that specializes in developing and commercializing innovative passive immunotherapeutic solutions. The company focuses on specific polyclonal immunoglobulins [F(ab’)₂] to address emerging infectious diseases and certain drug intoxications. By utilizing highly purified fragments of horse-specific polyclonal immunoglobulins, Fab'entech provides healthcare institutions with effective treatments for emergency situations. As a member of the LyonBiopôle cluster, the company is positioned within a network that fosters biotechnological advancements in the region.

Nexi Payments is a prominent payment services provider based in Italy, specializing in card issuing and merchant acquiring services. The company offers a comprehensive range of payment solutions, including credit, debit, and pre-paid card issuance, as well as point-of-sale (POS) management for merchants. Nexi operates across Europe and covers the full payment chain, excluding the card scheme itself. Its services can be delivered through partnerships with banks, enabling the provision of point-of-sale terminals and processing services, or directly to merchants, allowing for seamless payment processing and management. This positions Nexi as a key player in the European payment landscape, catering to both individual consumers and businesses.

Cyprus University of Technology (CUT) provides education and research in subjects that create significant economic, technological, and scientific developments. The University established in 2004, is a public institution located in Limassol that offers a comprehensive educational experience. CUT is known for providing quality education and conducting research in areas that contribute to economic, technical, and scientific advancements. With a focus on applied research, the university addresses significant challenges in science, technology, and knowledge, aiming to benefit both the state and society.

Stark Future was founded in 2019 by Anton Wass ( CEO ) and Paul Soucy ( CTO ). The company has Swedish roots and is located near barcelona, Catalonia , Spain. The company's team has former motocross world champion Sebastien Tortelli as test manager. Stark is Swedish for "strong," and the name represents the company's purpose.[6] Stark Future strives to reduce emissions and pollution by designing and building new technologies to help save the environment. On December 14, 2021, the company launched its first electric motorcycle: the Stark VARG (Swedish for "strong wolf"). The bike makes 80 horsepower and has a near-silent engine, a smartphone dashboard, and a bike setup app. 67 Eight Stark Future patents were used in the development of the vehicle. Advance sales of the Stark VARG electric motocross motorcycle reached €9 million in the first 24 hours after the motorcycle was announced. 910 In the first month, Stark Future earned 50 million euros. The company sold more than 5,000 motorcycles in less than two months after its launch.

Sunprime is an independent power producer based in Italy, founded in 2020 by Fulvio Mariani. The company specializes in the development of photovoltaic solar projects, focusing on providing no-cost installation of solar panels on rooftops. This innovative business model allows customers to enhance their sustainability efforts and increase the value of their properties without any upfront investment. With a team experienced in engineering and construction, Sunprime is actively expanding its portfolio of solar initiatives across the country.

Elektrodistribucija Srbije doo Belgrade is a Serbian Public Electric Utility Company.

Iren SpA is a prominent multi-utility company based in Reggio Emilia, Italy, providing a wide range of services across several sectors. The company operates in electricity production and distribution, primarily utilizing hydro, thermal, and cogeneration sources, as well as thermal energy for district heating. It distributes natural gas through an extensive network of pipelines and serves hundreds of thousands of customers in various cities. Additionally, Iren manages integrated water services, with a significant network of pipelines and sewerage systems catering to millions of residents. The company is also involved in environmental services, including waste collection, disposal, and the operation of treatment plants, alongside services related to street lighting and traffic systems. With a portfolio that includes multiple hydroelectric and thermoelectric plants, as well as photovoltaic production facilities, Iren is recognized as a dynamic player in the Italian utility market.

Metlen Energy & Metals SA is a prominent industrial and energy company with a global footprint across all five continents. It operates primarily in two segments: new energy and metallurgy, with the new energy segment generating the majority of its revenue. The company emphasizes sustainability and the principles of the circular economy, actively engaging in the development of extensive energy infrastructure projects. Metlen is notable for its comprehensive approach, integrating its metallurgy and energy sectors to create synergies. The company derives a significant portion of its revenue from Greece while maintaining a presence in markets across forty countries.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.

Energy Dome is an Italian company based in Lonate Pozzolo that specializes in long-duration electricity storage using liquid carbon dioxide. The company has developed a low-cost and efficient technology that employs a closed-loop thermodynamic process to store energy, making renewable power more dispatchable. By focusing on energy storage solutions, Energy Dome aims to facilitate the transition to renewable energy and contribute to the decarbonization of the energy industry. Its innovative approach seeks to address climate change challenges by significantly reducing greenhouse gas emissions, thereby promoting a more sustainable future.

Repsol is a Spanish integrated energy company that specializes in oil and gas production, as well as renewable energy solutions. With a daily production of 599,000 barrels of oil equivalent and proven reserves totaling 1.8 billion barrels, Repsol maintains a significant presence in the global energy market. The company operates a downstream segment with a refining capacity of 1 million barrels per day, complementing its upstream activities. Repsol is also focused on innovation and sustainable energy, having developed a renewable power generation capacity of 2.8 gigawatts. With operations in key energy regions such as Brazil, Russia, and the United States, Repsol is dedicated to creating a new energy model that encompasses both traditional and renewable energy sources.

Endesa is an electric utility company headquartered in Madrid, Spain, that generates, distributes, and supplies electricity primarily in Spain and Portugal. Founded in 1944, the company has an installed generation capacity of 22 gigawatts, utilizing a diverse mix of energy sources, including hydroelectric, nuclear, coal, natural gas, oil, solar, and wind. Endesa serves approximately 11.2 million customers and employs over 10,000 people. In addition to its core electricity services, Endesa operates in the natural gas sector and provides energy-related services, emphasizing a commitment to sustainability and technological innovation to address current and future energy challenges. The company also supplies gas to retail and business customers in Spain and France.

Trucksters is a Madrid-based freight startup that provides long-haul transport services through a unique relay system. This innovative approach utilizes big data and artificial intelligence to enhance the efficiency of long-distance road transit. By implementing relays, Trucksters enables trucks to remain in continuous motion, significantly reducing delivery times and transportation costs. The company operates throughout the European Union and serves over 500 shippers, contributing to the electrification agenda and improving the working conditions for drivers. Through its advanced logistics solutions, Trucksters aims to optimize the global road freight industry.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

TIM, an Italian telecommunications company and a key player in the Telecom Italia Group, is a leader in the telephony sector in Italy and also operates in Brazil. Founded in 2014, TIM Ventures serves as the corporate venture arm of Telecom Italia, focusing on investments in various sectors including internet technology, digital life, mobile evolution, e-learning, and green technology. The company offers startups consulting services and support, emphasizing investments in companies that leverage disruptive technologies, particularly in areas such as enterprise applications, telecommunications, and sustainability.

Illimity Bank, founded in 2018 and headquartered in Milan, Italy, is a commercial bank that delivers digital direct banking services to both retail and business clients. The bank specializes in providing corporate credit, managing non-performing loan (NPL) portfolios, and offering financing solutions specifically tailored for small and medium-sized enterprises (SMEs). Additionally, Illimity Bank engages in investment banking activities, including the establishment and management of investment funds and facilitating initial public offerings. With a focus on addressing the challenges posed by distressed credit and the increasing prevalence of bad loans, Illimity Bank aims to support its clients through innovative financial solutions.

SiPearl is a French semiconductor company established in 2019, headquartered in Maisons-Laffitte, Île-de-France, with research and development centers located in France, Germany, and Spain. The company specializes in the design of high-performance, low-power microprocessors intended for exascale supercomputers, aligning its product development with the European Union’s technological goals. Its first microprocessor range, Rhea, is set for commercialization in early 2024 and is based on the Arm Neoverse V1 architecture. SiPearl is committed to manufacturing Rhea using advanced processes from TSMC, ensuring state-of-the-art performance. The microprocessors are aimed at a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, serving scientific researchers and major players in the IT, electronics, and automotive sectors.

Reden Solar specializes in the development, financing, construction, and operation of solar photovoltaic power plants across Europe and Latin America. With an installed portfolio of 762 megawatts and an additional 15 gigawatts under development, the company primarily focuses on markets in France and Spain, while also expanding its operations in Greece and Italy. Reden Solar provides a variety of photovoltaic solutions, including agricultural greenhouses, ground-mounted systems, shelters, and rooftop installations, aimed at promoting sustainable energy production and contributing to environmental conservation.

Orange is a digital operator that offers mobile and internet services in Europe and Africa, and corporate telecommunication services worldwide. The group operates under the brand name Orange Business Services, both in France and internationally, in the business communication and IT services markets. Orange Business Services offers a range of services to large corporates, local authorities, and SMEs in France, as well as to multinationals around the world, supporting the implementation of their communication projects. To do so, OBS offers a full range of voice and data, IT, and integrated services. The Orange Fabs is an international network of startup drivers that provides startups in the digital space with advice, training, and events, as well as resources and expertise. Orange was founded in 1991 and is headquartered in Paris, France with a presence in 30 countries.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

AB Science is a France-based pharmaceutical company founded in 2001 by a team of researchers, clinicians, and entrepreneurs. It specializes in the research, discovery, development, and marketing of protein kinase inhibitors, focusing on targeted therapies using tyrosine kinase inhibitors. The company aims to address significant unmet medical needs in various fields, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases. AB Science is committed to innovating and developing new drugs that can significantly improve the lives of patients and enhance treatment outcomes in both human and veterinary medicine.

Independent Power Transmission Operator (IPTO or ADMIE) operates the Transmission System of Greece's Electricity Transmission System. Therefore, IPTO ensures the electricity supply to Greece is adequately, safely, efficiently, and reliably handled in accordance with its operational, control, maintenance, and development duties. Additionally, IPTO operates the Greek electricity market according to the principles of transparency, equality and free competition

Cellectis S.A. is a clinical-stage biotechnological company headquartered in Paris, France, focused on developing immuno-oncology products utilizing gene-edited T-cells that express chimeric antigen receptors to target cancer cells. The company's primary portfolio includes several allogeneic T-cell product candidates such as UCART19, designed for treating CD19-expressing hematologic malignancies, and UCART123 for acute myeloid leukemia. Additional candidates include ALLO-501 for relapsed/refractory diffuse large B-cell lymphoma, UCART22 for B-cell acute lymphoblastic leukemia, and products targeting multiple myeloma, such as UCARTCS1 and ALLO-715. In addition to its therapeutic developments, Cellectis also produces high oleic soybean oil and other agricultural products. The company has established strategic partnerships with various institutions, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to innovate in the field of gene editing and immunotherapy.

Advicenne is a late-stage biopharmaceutical company founded in 2007 and headquartered in Nîmes, France. The company focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly targeting orphan renal diseases and niche neurology indications. Its lead drug candidate, ADV7103, is undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the lives of patients from early childhood through adulthood.

OVH APAC is a leading cloud provider known for its innovative and cost-effective solutions tailored for a diverse clientele, ranging from startups to large enterprises. Founded in 1999 by Octave Klaba and based in France, OVH offers a comprehensive portfolio of services, including web hosting, dedicated servers, cloud solutions, domain registration, and VOIP telephony. The company distinguishes itself through its proprietary global fiber-optic network and green data centers, which enable optimal performance and reliability. With a commitment to research and development and complete control over its supply chain, OVH delivers high-quality products and exceptional customer service. Additionally, OVH has established a strong partnership with VMware, integrating advanced software solutions to enhance network performance and streamline service delivery for its customers. As a result, OVH is recognized as one of the top internet hosting companies globally, serving millions of customers with cutting-edge technology and expertise.

The International Fund for Agricultural Development (IFAD) is a United Nations agency established in 1977 and headquartered in Rome, Italy. It focuses on agricultural development in developing countries by providing grants and low-interest loans to rural projects. IFAD aims to empower rural populations to enhance food security, improve nutrition, and increase their incomes. In addition to financing sovereign governments, IFAD has adopted a private sector investment strategy to support small and medium-sized enterprises, cooperatives, and smallholder farmers. This approach allows IFAD to fund a diverse range of initiatives that boost productivity, promote climate-smart practices, and foster resilience among rural communities. By attracting private sector funding, IFAD expands its capacity to contribute to sustainable agricultural development and poverty reduction in rural areas.

GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, focused on developing gene therapy treatments for retinal degenerative diseases and neurodegenerative conditions affecting the central nervous system. Utilizing its core technology platforms—Mitochondrial Targeting Sequence and Optogenetics—the company aims to preserve and restore vision in patients with severe retinal disorders. Its lead product candidates include GS010, an AAV2-based gene therapy currently in Phase III trials for treating Leber hereditary optic neuropathy caused by mutations in the ND4 gene, and GS030, which is undergoing Phase I/II trials for retinitis pigmentosa and geographic atrophy in dry age-related macular degeneration. In addition to these, GenSight is advancing several products in preclinical stages targeting various ophthalmic and neurodegenerative diseases. Founded in 2012, the company is dedicated to innovative approaches that aim to prevent vision loss and improve the quality of life for affected patients.

Autonom Group is a family-owned mobility network that specializes in transportation and car rental services across Romania, Hungary, and Serbia. The company offers a comprehensive range of services, including car rentals, purchase-use vehicles, operating leases, equipment leases, road assistance, transfer services, and fleet management. Autonom Group is committed to long-term growth driven by client satisfaction and the development of its employees. The company prioritizes profitability and financial stability as natural outcomes of its focus on customer service and employee evolution.

Prophesee SA, founded in 2014 and based in Paris, France, specializes in advanced machine vision sensors and systems through its innovative neuromorphic vision technology. Originally known as Chronocam SAS, the company rebranded in 2018 to reflect its pioneering approach to computer vision, which mimics the human eye and brain by detecting essential motion information rather than capturing a series of images. This unique Metavision® method enables Prophesee to achieve exceptional performance metrics, including high-speed time resolution, dynamic range, and significant reductions in data volume and power consumption. Its technology caters to a diverse range of industries, including biomedical, gaming, industrial automation, mobile devices, robotics, security, and automotive applications. Prophesee's team of over 100 engineers holds more than 50 international patents and has established a global presence with offices in cities such as Grenoble, Shanghai, Tokyo, and Silicon Valley, supported by a network of prominent investors.

MithraSol specialises in the identification, development, construction and operation of Spanish solar photovoltaic assets and currently has 50MW of assets in development across twelve projects spanning central and southern Spain.

Opdenergy is an independent renewable energy producer with over 15 years of experience, specializing in solar photovoltaic and onshore wind energy. The company operates projects across several countries, including Spain, Chile, Italy, Mexico, and the USA, with the majority of its revenue generated from the Spanish market. Opdenergy's diverse portfolio reflects its commitment to advancing renewable technologies and contributing to sustainable energy solutions.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies for patients with significant unmet medical needs, particularly in fibrosis, lysosomal storage disorders, and oncology. The company specializes in drugs that target nuclear receptors, transcription factors, and epigenetic modulation. Its primary product candidate, lanifibranor, is being developed for the treatment of non-alcoholic steatohepatitis (NASH), a condition currently lacking approved therapies. Inventiva has established a robust pipeline supported by a proprietary discovery engine, a dedicated research and development facility, and a skilled team with extensive experience in drug development. In addition to advancing lanifibranor, the company is also working on several earlier-stage programs aimed at addressing various medical conditions. All operations are conducted in France.

Cabify is a ride-sharing company founded in 2011 and headquartered in Madrid, Spain. It connects private users and businesses with transportation options that meet their needs, focusing on enhancing the overall travel experience for both passengers and drivers. The company offers on-demand services that include clean, modern vehicles equipped with amenities such as music, magazines, and water, all driven by specially trained drivers. Cabify emphasizes affordability, safety, and reliability in its rides, aiming to improve mobility in urban areas and contribute positively to the communities it serves. By prioritizing customer satisfaction and accessibility, Cabify seeks to redefine transportation in cities.

Priothera Ltd is a clinical-stage company based in Dublin, Ireland, with an additional location in Saint Louis, France. It specializes in the development of orally applied sphingosine 1 phosphate (S1P) receptor modulators aimed at treating haematological malignancies. The company's primary focus is on its lead product, mocravimod, which is designed to enhance the curative potential of allogeneic haematopoietic stem cell transplants. By reducing the egress of T cell subsets from lymphatic tissues, Priothera's modulators aim to provide dual inhibition of graft versus host disease while also promoting graft versus leukemia effects, ultimately improving patient outcomes in this challenging area of medicine.

Stilla Technologies is a biotechnology company based in Villejuif, France, with an additional location in Beverly, Massachusetts. Founded in 2013, the company specializes in accelerating the development of next-generation genetic tests through its innovative digital PCR (dPCR) solution, the Naica System. This platform leverages advanced microfluidic technology to provide a flexible and accessible tool for high-resolution genetic analysis. By enabling compatibility with multiple chemistries and offering multiplex capabilities, Stilla Technologies aims to simplify the processes of image analysis and data exploration for researchers in various fields, including life sciences and therapeutics. The company's mission is to make digital PCR a standard tool across all areas of genetic research and application.

OSE Immunotherapeutics SA is a clinical-stage biotechnology company based in Nantes, France, specializing in the development of innovative immunotherapies aimed at immune activation and regulation, particularly in the areas of immuno-oncology and autoimmune diseases. The company's product portfolio includes Tedopi, which is in Phase III clinical trials for lung cancer and Phase II for pancreatic cancer; BI 765063, currently in Phase I trials for solid tumors; and OSE-703, a humanized monoclonal antibody in preclinical development for various cancers. Additionally, OSE Immunotherapeutics is advancing FR104, which is in Phase I trials for rheumatoid arthritis, and OSE-127, a humanized monoclonal antibody in Phase I trials for inflammatory autoimmune diseases. The company collaborates with notable partners such as GERCOR, Memorial Sloan Kettering Cancer Center, Boehringer Ingelheim, Servier, and HalioDx. OSE Immunotherapeutics was previously known as OSE Pharma SA before its name change in May 2016.

Bouygues Telecom is a prominent telecommunications operator in France, offering a wide range of services that include mobile, fixed-line, television, internet, and cloud computing. The company serves approximately 11.1 million mobile customers and 2.1 million fixed broadband customers, including over 1.5 million professional and corporate clients. Renowned for its innovative approach, Bouygues Telecom has introduced several pioneering products, such as the first unlimited call plans, fixed-mobile convergence offers for corporate customers, and the quadruple play solution known as ideo. The company also launched B&YOU, a web-only offer that revolutionized mobile telephony. With a mobile network that covers 99% of the population and a rapidly expanding 4G network, Bouygues Telecom is committed to enhancing customer experience through its dedicated team of over 9,000 employees and a robust customer service framework that includes 2,000 advisers and 2,500 sales staff. The company's focus on innovation and customer satisfaction positions it as a key player in the French telecommunications market.

Worldsensing is a leading provider of Internet of Things (IoT) solutions, specializing in low-power wireless sensing networks. The company has developed comprehensive applications for smart cities and industrial sectors, focusing on mobility and industrial solutions. Its mobility portfolio includes Bitcarrier, a real-time traffic flow management system, and Fastprk, a widely recognized smart parking solution. In industrial applications, Worldsensing offers the LS-G6 platform, which monitors assets in challenging locations such as bridges, tunnels, and power lines. Founded in 2010, the company has secured funding through various investment rounds, with notable contributions from Fundación Jose Manuel Entrecanales and Kibo Ventures. Worldsensing has received multiple accolades for its innovations, including awards for Fastprk and Bitcarrier, and its CEO, Ignasi Vilajosana, was named the first Spanish Endeavor Entrepreneur in 2014. With offices in Barcelona and London, the company employs a team of over 40 professionals dedicated to enhancing infrastructure through advanced sensing technologies.

Iliad Italia is an Italian telecommunications company that provides mobile telecommunication services and smartphone retail. It offers a range of prepaid and postpaid voice calling and SMS packages, as well as internet services, all at competitive prices. The company operates integrated 2G, 3G, and 4G networks, catering to various customer needs in the rapidly evolving telecommunications market.

Advicenne is a late-stage biopharmaceutical company founded in 2007 and headquartered in Nîmes, France. The company focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly targeting orphan renal diseases and niche neurology indications. Its lead drug candidate, ADV7103, is undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the lives of patients from early childhood through adulthood.

Iberdrola is a leading global utility company engaged in the production, distribution, and retail of electricity and gas across nearly 40 countries. With a diverse portfolio of 56 gigawatts, it primarily generates electricity from nuclear, fossil-fuel, hydroelectric, and renewable energy sources, with wind power representing approximately 40% of its capacity. The company operates significant electricity and distribution networks in Spain, the UK, Brazil, and the US, where it maintains a strong presence. Iberdrola is committed to advancing the energy transition through a sustainable business model that emphasizes renewable energy, smart grids, large-scale energy storage, and digital transformation, aimed at delivering innovative products and services to its customers. In addition to its generation activities, Iberdrola is involved in gas storage and supply, reinforcing its position as a comprehensive energy provider.

Resalta is an energy efficiency company based in Ljubljana-Črnuče, Slovenia, founded in 2011. The company focuses on reducing environmental footprints and managing energy consumption for clients across various sectors, including food, manufacturing, automotive, and finance. Resalta designs energy efficiency projects tailored to the specific consumption needs of its clients, ensuring that solutions are both innovative and reliable. Additionally, the company develops and implements renewable energy projects to enhance the use of sustainable energy sources in the countries where it operates. By providing comprehensive services in energy efficiency and renewable energy, Resalta aims to improve clients' competitiveness and overall environmental impact.

Median Technologies SA specializes in the development and marketing of software products and platforms for medical image analysis, primarily focusing on oncology. Founded in 2002 and headquartered in Valbonne, France, the company operates internationally, offering solutions that enhance the diagnosis and treatment of cancer patients. Its key products include iBiopsy, an imaging platform that utilizes AI for biomarker identification, and iSee, which supports image analysis and management in clinical trials. Additionally, Median provides a range of imaging contract research services, including study startup, data management, and scientific consulting to optimize clinical trials. The company collaborates with a contract research organization and Canon to enhance its imaging technologies and services, aiming to improve patient care and streamline drug development processes.

MolMed S.p.A. is an Italy-based medical biotechnology company dedicated to the research, development, and clinical validation of innovative cancer therapies. Its pipeline features several antitumor therapeutics currently in clinical and preclinical phases. Zalmoxis® (TK) is a cell-based therapy designed to facilitate bone marrow transplants from partially compatible donors without requiring post-transplant immune suppression; it is currently in Phase III trials for high-risk acute leukemia and is undergoing evaluation by the European Medicines Agency for Conditional Marketing Authorization. Another key product, NGR-hTNF, is a novel treatment for solid tumors that targets the blood vessels supplying the tumor mass, and it is being investigated in an extensive clinical program. Additionally, MolMed is developing CAR-CD44v6, an immuno-gene therapy project aimed at treating various hematological malignancies and epithelial tumors, which is in preclinical development. The company also collaborates with third parties on cell and gene therapy projects, providing expertise and resources for trials ranging from preclinical stages to Phase III.

Orange is a digital operator that offers mobile and internet services in Europe and Africa, and corporate telecommunication services worldwide. The group operates under the brand name Orange Business Services, both in France and internationally, in the business communication and IT services markets. Orange Business Services offers a range of services to large corporates, local authorities, and SMEs in France, as well as to multinationals around the world, supporting the implementation of their communication projects. To do so, OBS offers a full range of voice and data, IT, and integrated services. The Orange Fabs is an international network of startup drivers that provides startups in the digital space with advice, training, and events, as well as resources and expertise. Orange was founded in 1991 and is headquartered in Paris, France with a presence in 30 countries.

Prophesee SA, founded in 2014 and based in Paris, France, specializes in advanced machine vision sensors and systems through its innovative neuromorphic vision technology. Originally known as Chronocam SAS, the company rebranded in 2018 to reflect its pioneering approach to computer vision, which mimics the human eye and brain by detecting essential motion information rather than capturing a series of images. This unique Metavision® method enables Prophesee to achieve exceptional performance metrics, including high-speed time resolution, dynamic range, and significant reductions in data volume and power consumption. Its technology caters to a diverse range of industries, including biomedical, gaming, industrial automation, mobile devices, robotics, security, and automotive applications. Prophesee's team of over 100 engineers holds more than 50 international patents and has established a global presence with offices in cities such as Grenoble, Shanghai, Tokyo, and Silicon Valley, supported by a network of prominent investors.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Mobidiag is a Finnish-French biotechnology company that focuses on developing and marketing innovative molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. Utilizing established qPCR and microarray technologies, Mobidiag provides a wide array of fast, reliable, and cost-effective diagnostic tests and automated platforms suitable for laboratories of various sizes. Their offerings enable the detection of a broad spectrum of clinically relevant bacteria, parasites, viruses, and antibiotic resistance markers, thereby facilitating quicker diagnosis and treatment in hospitals, laboratories, and clinics.

CARMAT is a France-based medtech company that specializes in the development and manufacture of bioprosthetic artificial hearts aimed at treating patients with severe heart failure. Founded in 2008 and located in Vélizy-Villacoublay, the company produces biocompatible and auto-regulated total artificial hearts that closely mimic the human heart's functionality. These devices are designed for individuals experiencing chronic terminal heart failure classified as NYHA class IV or those suffering from acute terminal heart failure following a major heart attack. CARMAT's innovative solutions target patients who are not suitable for heart transplantation and have exhausted other treatment options, providing a reliable new therapeutic alternative. In addition to the artificial hearts, CARMAT also develops the associated power supply and control systems, including remote diagnosis capabilities.

MotorK is a software as a service (SaaS) provider focused on the automotive retail industry in the EMEA region, employing over 400 staff across eleven offices in eight countries, including Italy, Spain, France, Germany, Portugal, the UK, Belgium, and Israel. The company specializes in developing digital sales and marketing solutions that enhance customer experience for car manufacturers and dealers. MotorK offers a comprehensive suite of integrated digital products and services, including platforms for traffic acquisition, inventory management, sales operations, and promotional campaigns. Key products include WebSparK, a web module known for its technical and design excellence, and StockSparK, a stock management tool that aggregates and enhances inventory visibility for potential buyers. With a strong emphasis on innovation, MotorK boasts one of the largest research and development teams in the European automotive digital sales and marketing sector.

Mobidiag is a Finnish-French biotechnology company that focuses on developing and marketing innovative molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. Utilizing established qPCR and microarray technologies, Mobidiag provides a wide array of fast, reliable, and cost-effective diagnostic tests and automated platforms suitable for laboratories of various sizes. Their offerings enable the detection of a broad spectrum of clinically relevant bacteria, parasites, viruses, and antibiotic resistance markers, thereby facilitating quicker diagnosis and treatment in hospitals, laboratories, and clinics.

NAVYA is a leading French name in the autonomous vehicle market and in smart shared mobility solutions. With more than 200 employees in France (Paris and Lyon) and in the United States (Michigan), NAVYA develops, manufactures and commercializes autonomous, driverless, and electric vehicles that combine robotic, digital and driving technologies at the highest level. Since 2015, NAVYA has been the first to market and put into service autonomous mobility solutions, shuttles and cabs. NAVYA has a range of two autonomous vehicles: the AUTONOM®SHUTTLE, launched in September 2015, of which more than 100 have already been produced as of today and 89 sold in 17 countries as of June 30, 2018, notably in the United States, France, Germany, Switzerland, Japan and Australia, and the AUTONOM®CAB, unveiled in November 2017 and whose first road tests will start shortly.

October is a pan-European lending platform that aims to empower businesses by simplifying access to funding. Founded in France in 2014 under the name Lendix, the company emerged following regulatory changes that disrupted traditional banking practices. With offices in France, Spain, Italy, and the Netherlands, October operates an online marketplace that connects private investors with enterprises of various sizes. This platform allows investors to finance businesses directly, offering fully disclosed terms and facilitating a streamlined investment process. Institutional lenders complement individual contributions, ensuring borrowers benefit from high success rates and quick processing times. October's mission is to democratize finance, providing a secure and efficient way for individuals to invest in the real economy.

Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, the company specializes in developing innovative disease management solutions that leverage the understanding of the gut microbiome. Enterome focuses on creating biomarkers, companion diagnostics, and therapeutics targeted at microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company’s OncoMimic technology addresses cancer by mimicking tumor-associated antigens, thereby inducing a strong immune response against solid tumors. Enterome's drug candidates are designed to modulate the immune system and are currently advancing through clinical trials, with several programs in Phase 2 targeting challenging cancers such as glioblastoma, adrenal malignancies, and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts.

Forsee Power SAS is a French company specializing in the design and manufacture of smart battery systems. Founded in 2007 and based in Ivry-sur-Seine, it focuses on providing innovative solutions for the electric transportation sector, including electric and hybrid vehicles, trams, and marine applications. Additionally, Forsee Power produces modular battery systems for portable and mobile equipment, as well as energy storage solutions. The company's products cater to various markets, supplying power to devices such as medical equipment, electric scooters, and robotics. With a commitment to innovation and operational excellence, Forsee Power aims to support a sustainable energy transition and enhance the lifecycle of smart mobility and connected devices.

SunPartner develops and commercializes innovative technologies adapted to communication, energy, transportation, and building needs. It offers Wysips Crystal, an ultra-thin and transparent photovoltaic material with an optical system designed for emissive screens for smartphones and smartwatches; Wysips Graphics masks solar cells for connected devices; Wysips Reflect that can be integrated into any kind of reflective screen; Wysips Cameleon for signs and billboard; and Light-Fidelity or Visible Light Communication, a communication technology that transmits data over visible light waves and has applications in location-based services, electromagnetic sensitive places, shopping 2.0, and smartCities. SunPartner is a France-based company that was founded in 2008.

Electro Power Systems (EPS) operates in the sustainable energy sector, focusing on hybrid-storage solutions and microgrids that convert intermittent renewable energy into reliable power sources. Headquartered in Paris, with research, development, and manufacturing facilities in Italy, EPS has developed innovative energy storage technologies protected by 125 patents and applications, built on over a decade of research and development. The company aims to stabilize electrical grids with high levels of renewable energy integration in developed nations and to provide affordable off-grid power solutions in emerging economies without relying on subsidies. EPS has successfully executed 36 large-scale projects, including off-grid hybrid systems powered by renewable energy and energy storage, totaling over 35 MW of installed power. These systems serve more than 165,000 customers daily and include an additional 18 MW of grid support systems, resulting in a total capacity output of 47 MWh across 21 countries, spanning Europe, Latin America, Asia, and Africa.

Upstream S.A. is a mobile marketing technology company that operates the MINT platform, designed for mobile operators, agencies, e-commerce brands, and application developers. Established in 2001 and headquartered in Athens, Greece, with offices in key cities worldwide, Upstream focuses on enhancing mobile commerce in high-growth markets. The platform facilitates mobile interactions and customer engagement, enabling users to access and pay for digital subscription services seamlessly. Upstream partners with over 50 mobile operators across 43 markets in Latin America, Africa, the Middle East, CIS, and Southeast Asia, allowing it to reach more than one billion consumers. The company provides a range of solutions, including marketing promotions, loyalty programs, and direct carrier billing, and has successfully converted 65 million consumers into paying customers through subscription micro-payment models.

Mobidiag is a Finnish-French biotechnology company that focuses on developing and marketing innovative molecular diagnostic solutions aimed at detecting gastrointestinal infections, antimicrobial resistance, healthcare-associated infections, respiratory infections, and sepsis. Utilizing established qPCR and microarray technologies, Mobidiag provides a wide array of fast, reliable, and cost-effective diagnostic tests and automated platforms suitable for laboratories of various sizes. Their offerings enable the detection of a broad spectrum of clinically relevant bacteria, parasites, viruses, and antibiotic resistance markers, thereby facilitating quicker diagnosis and treatment in hospitals, laboratories, and clinics.

The company develops and delivers technology for converting ocean waves to electricity. AW-Energy has developed WaveRoller - a fully submerged wave energy converter which utilizes wave surge phenomenon. This commonplace effect is observed in near-shore waters where the circular motion of water particles present in open sea waves changes into elliptical circulation due to more shallow bottom. Before the waves break, typically at the depth of 8-20 metres this elliptical motion is so flat that it is essentially a horizontal back-and-forth movement of water. WaveRoller device is a Panel anchored at its base on the sea bed. The back and forth movement of the wave surge moves the Panel, transferring the kinetic energy to piston pumps. The pumps create a great deal of pressure which is fed into a combination of hydraulic motor/generator, which in turn produces electricity. The nominal capacity of a single commercial-scale Panel ranges between 500 – 1000 kW, depending on the wave resources available on the site. WaveRoller has the ability to generate energy on a wide spectrum of wave states and is also well suited for locations where wave periods are long and the swell is strong. A series of WaveRoller devices can be combined into an array, thus resulting in a wave farm. Since the plant construction is modular with a high degree of independence between individual units, there is no natural upper limit to the number of WaveRoller units that can be used, therefore offering a high level of scalability and reliability. The electricity output from an individual Panel is connected to a hub/substation, thus making it easy to plug-in new units in separate project development stages, as the new capacity is added to the farm. Also, any potential underperformance or service & maintenance breaks of individual units have no impact on the remaining units, thus ensuring uninterrupted power output from the overall farm. The first prototypes were designed and patent applications were filed as early as in 1999, when Rauno Koivusaari, the original inventor co-operated with Fortum Research Centre during the conceptual phase. Since then the technology has evolved following numerous laboratory and wave-tank test trials and ongoing mathematical simulations. Open sea trails started in 2004 and included the Gulf of Finland, marine tests conducted in the European Marine Energy Centre (EMEC), Scotland, and an own testing site in Peniche, Portugal. The subsequent successes and encouraging test results led to continuous increase in the scale of the demonstration plant. The latest demonstration plant/farm consisting of three 100kW WaveRoller units (total nominal capacity of the farm 300kW) is to be deployed in Peniche, Portugal, during the second quarter of 2012. The final assembly is nearing completion in the first quarter of 2012 and will be awaiting suitable weather conditions for the deployment in the following months. The farm will be connected to national grid in Portugal. The company has already secured all the necessary permits and, additionally, holds a licence for 1MW grid connection.